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Abstract 
Background  Elevated resting heart rate and hypertension independently increase the risk of mortality. However, their combined ef-
fect on mortality in stages of hypertension according to updated clinical guidelines among elderly population is unclear. Methods  We fol-
lowed a cohort of 6100 residents (2600 males and 3500 females) of Kangwha County, Korea, ranging from 55 to 99 year-olds as of March 
1985, for all-cause and cardiovascular mortality for 20.8 years until December 31, 2005. Mortality data were collected through telephone 
calls and visits (to 1991), and were confirmed by death record matching with the National Statistical Office (19922005). Hazard ratios were 
calculated for all-cause and cardiovascular mortality by resting heart rate and hypertension defined by Eighth Joint National Committee crite-
ria using the Cox proportional hazard model after controlling for confounding factors. Results  The hazard ratios associated with resting 
heart rate > 80 beats/min were higher in hypertensive men compared with normotensives with heart rate of 61–79 beats/min, with hazard 
ratios values of 1.43 (95% CI: 1.001.92) on all-cause mortality for prehypertension, 3.01 (95% CI: 1.07–8.28) on cardiovascular mortality 
for prehypertension, and 8.34 (95% CI: 2.5228.19) for stage 2 hypertension. Increased risk (HR: 3.54, 95% CI: 1.16–9.21) was observed 
among those with both a resting heart rate ≥ 80 beats/min and prehypertension on cardiovascular mortality in women. Conclusions  Indi-
viduals with coexisting elevated resting heart rate and hypertension, even in prehypertension, have a greater risk for all-cause and cardiovas-
cular mortality compared to those with elevated resting heart rate or hypertension alone. These findings suggest that elevated resting heart 
rate should not be regarded as a less serious risk factor in elderly hypertensive patients. 
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1  Introduction 
Elevated resting heart rate (ERHR) has been reported as 
a major risk factor for cardiovascular diseases (CVDs),[1–3] 
sudden death,[4] heart failure[1] and all-cause mortality[1,2,5] in 
the general population. Heart rate has been implicated as a 
prognostic factor of CVDs like myocardial infarction,[6] co-
ronary heart disease,[7] or chronic heart failure (CHF).[8] 
The predictive value of heart rate was even higher than 
that of blood pressure (BP) in some reports.[9] The signifi-
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cant role of heart rate among hypertension patients has been 
reported. Heart rate is an independent risk factor of mortal-
ity in hypertension patients after adjusting β-blocker use or 
other combined risk factors.[10] Heart rate and BP may have 
synergistic effects on CVD complications.[10,11] Heart rate of 
hypertensive patients has been highlighted in several stud-
ies.[11–14] The risk of CVDs was 1.48 (95% CI: 1.22–1.78) in 
hypertensive patients with tachycardia exceeding 80 beats/ 
min.[14] The combined risk of ERHR and systolic BP has 
also been reported in chronic heart failure patients.[15] 
The 2014 Eighth Report of the Joint National Committee 
(JNC-8) expert panel, as a foundation of the standardized 
treatment based on evidences, restructured the stages of 
hypertension: prehypertension, stage 1, and stage 2.[16] Pre-
hypertension suggested in the recent clinical guideline raise 
the all-cause mortality.[17] However, previous studies on 
heart rate in hypertensive cases defined hypertension as  
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systolic BP > 140 mmHg or diastolic BP > 90 mmHg,[11,14] 
controlled or uncontrolled hypertension,[12] or as a continu-
ous variable.[13] 
Therefore, these previous reports provide insufficient in-
formation for clinical decision based on JNC-8 guideline. 
The information on the predictive risk of the each hyperten-
sion stage combined with heart rate might have more clini-
cal value. In particular, the JNC-8 expert panel recom-
mended an increased BP target in patients ≥ 60 years of 
age,[16] for whom the achievement of BP target should re-
quire close monitoring because the new target might be 
more permissive for higher CVD risk.[18] Therefore, infor-
mation for risk assessment in each stage of hypertension is 
needed in these age group. 
The purpose of this study was to examine the effect of 
ERHR in stages of hypertension according to JNC-8 on 
all-cause and cardiovascular mortality in a large cohort of 
Koreans over a 20.8-year follow-up. 
2  Methods 
2.1  Study population 
This study used the data of the Kangwha cohort that have 
been collected since March 1985. Kangwha County consists 
of several islands located approximately 50 km west of 
Seoul. Its population was 71,116 in 1993.[19,20] In February 
1985, 9378 residents in Kangwha County ≥ 55 years of age. 
Among these residents, 67.9% (6372 residents) participated 
in the interviews and measurements of heart rate, BP, and 
body weight. Those who had a stroke or coronary heart dis-
ease (n = 135) or had no information on heart rate (n = 137) 
were excluded. The final study population recruited was 
6100 (2600 males and 3500 females). The Institutional Re-
view Board of Human Research of Yonsei University ap-
proved the study (Approval No. 4-2007-0182). 
2.2  Baseline data collection and follow-up 
The primary survey for the Kangwha cohort was con-
ducted over one month in March 1985 by 26 trained inter-
viewers after one week of training. Each participant was 
interviewed using a structured questionnaire for demographic 
data comprising education, occupation, health conditions at 
entry, health behaviors, diet, and other factors (smoking and 
drinking). Height and weight were measured by trained in-
vestigators. Body mass index (BMI) was calculated as the 
ratio of weight to height squared (kg/m2). Concerning chronic 
conditions, the study participants were asked to answer yes or 
no to the question “Do you have any chronic disease or past 
accident or injury due to which you feel uncomfortable in 
your daily life including work?” The study participants were 
followed up until December 31, 2005, for a maximum pe-
riod of follow-up for mortality of 20.8 years. 
2.3  Heart rate and BP measurements 
BP was measured in a seated position by a trained inves-
tigator using a standard mercury sphygmomanometer.[20] 
The first and fifth Korotkoff sounds were recorded as sys-
tolic and diastolic BP, respectively. The cut-off point de-
fined in previous studies was used to categorize the resting 
heart rate.[17,21,22] Participants were categorized into three 
groups based on resting heart rate: < 61 beats/min, 61–79 
beats/min, and ≥ 80 beats/min. BP was classified into four 
categories using JNC-8 on Detection, Evaluation, and 
Treatment of High Blood Pressure classification.[16] 
2.4  Mortality data 
Data for those who died from March 15, 1985 to De-
cember 31, 1991 were collected either through telephone 
calls and visits by trained surveyors twice a year or from 
records of burial and death certificates from the Eup and 
Myeon administrative branch offices of the local govern-
ment in Korea. Deaths among subjects from January 1, 
1992 to December 31, 2005 were confirmed by matching 
the information to death records from the National Statisti-
cal Office. The main outcome variables for this study were 
death from all causes and CVD as defined by the Interna-
tional Classification of Disease, 10th edition. 
2.5  Statistical analyses 
Continuous variables were shown as means ± SD and 
were compared using one-way analysis of variance. Cate-
gorical variables were shown as counts and percentages and 
were compared using Chi-square tests for association. The 
Cox proportional hazard model was used to test the rela-
tionship among resting heart rate status, BP level at baseline 
and subsequent risk for all-cause and cardiovascular mortal-
ity. In the model of combined effect, we created twelve dif-
ferent categories of resting heart rate status and BP level 
with all the different combinations. The combination of 
heart rate (61–79 beats/min) and normal level of BP was 
considered as the reference group. Variables adjusted for in 
the model were age (as a continuous variable), BMI (as a 
continuous variable), education status (no education/elemen-
tary/high), smoking status (never/former/current), alcohol 
use (non-drinker/drinker), occupation (agriculture/other), 
and chronic disease (ever/never). The analyses were per-
formed for men and women separately due to the gender 
differences in all-cause and CVD-related mortality. The 
outcome of interest was vital status. Hazard ratios and 95% 
confidence intervals (CIs) were expressed for the results. A 
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significance level of P ≤ 0.05 was used for all tests. Analy-
ses were performed using SAS Windows Version 9.3. 
3  Results 
The mean age of men and women was 66.2 ± 7.2 years 
and 66.9 ± 8.5 years, respectively. The average resting heart 
rate for men was 73.3 ± 9.7 beats/min compared to 71.8 ± 9.1 
beats/min for women. Men were more likely to be cigarette 
smokers and alcohol users. Almost all subjects (98.8%) had 
received no formal education or had been educated only at 
an elementary school level. During the 20.8 years of follow 
up, 4065 (66.6%) people comprising 1990 men and 2075 
women died. 
General characteristics of the study participants accord-
ing to resting heart rate categories are presented in Table 1. 
Those who had a heart rate ≥ 80 beats/min displayed a 
higher BP, higher proportions of smoking and alcohol 
drinking, and a higher death rate. 
Table 2 showed the hazard ratios for all-cause and car-
diovascular mortality according to resting heart rate catego-
ries. heart rate 61–79 beats/min served as the reference 
group. On univariate analyses for both genders, resting heart 
rate ≥ 80 beats/min was significantly associated with in-
creased all-cause and CVD mortality. The magnitude of the 
risk for all-cause mortality was slightly higher in women 
than men, but less strong for CVD mortality. On multivari-
ate analyses, the hazard ratios were reduced only slightly, 
but remained significant for all-cause and CVD mortality 
both in men and women. 
The hazard ratios for all-cause mortality associated with 
prehypertension was 1.01 (95% CI: 0.63–1.60) for resting 
heart rate < 61 beats/min, 1.15 (95% CI: 0.88–1.55) for rest-
ing heart rate 61–79 beats/min, and 1.43 (95% CI: 1.00–1.92) 
for resting heart rate ≥ 80 beats/min among men. The re-
sults indicated that the combined effect of resting heart rate 
and hypertension on risk of all-cause mortality increased 
slightly with the increasing resting heart rate. Compared 
to the reference group, men with a resting heart rate ≥ 
80 beats/min and stage 2 hypertension had the highest haz-
ard ratios for CVD mortality, 8.34 (95% CI: 2.52–28.19; 
Table 3). 
Table 1.  General characteristics of the study population in the Kangwha cohort study categorized by heart rate. 
Heart rate category, beats/min 
Variable 
 < 61 (n = 554) 61–79 (n = 4260)    ≥ 80 (n = 1286)  P value 
Age, yrs  66.6 ± 8.3 66.4 ± 7.9 67.3 ± 7.9 0.0023 
SBP, mmHg 144.7 ± 32.3 147.0 ± 31.0 152.8 ± 33.1 < 0.0001 
DBP, mmHg 68.5 ± 21.4 71.0 ± 19.3 70.9 ± 21.3 0.0824 
BMI, kg/m2 22.0 ± 3.2 22.0 ± 3.4 21.6 ± 3.3 0.0445 
Gender     
Men 222 (40.0%) 1754 (41.1%) 624 (48.5%) < 0.0001 
Women 332 (59.9%) 2506 (58.8%) 662 (51.4%)  
Education     
No 361 (65.1%) 2704 (63.4%) 809 (62.9%) 0.7021 
Elementary 176 (31.7%) 1376 (32.3%) 421 (32.7%)  
High 17 (3.0%) 180 (4.2%) 56 (4.3%)  
Smoking     
Never 296 (53.4%) 2277 (53.4%) 548 (42.6%) < 0.0001 
Former 28 (5.0%) 180 (4.2%) 54 (4.2%)  
Current 230 (41.5%) 1803 (42.3%) 684 (53.1%)  
Drinking     
Non-drinking 383 (69.1%) 2912 (68.3%) 746 (58.0%) < 0.0001 
Drinking 171 (30.7%) 1348 (31.7%) 540 (42.0%)  
Occupation     
Agriculture 458 (82.6%) 3520 (82.6%) 1074 (83.5%) 0.7581 
Other 96 (17.3%) 740 (17.3%) 212 (16.4%)  
Chronic disease     
Ever 302 (54.5%) 1915 (44.9%) 655 (50.9%) < 0.0001 
Never 252 (45.4%) 2345 (55.0%) 631 (49.1%)  
Death 371 (66.9%) 2753 (64.6%) 941 (73.2%) < 0.0001 
Data are presented as mean ± SD or n (%) unless otherwise specified. BMI: body mass index; DBP: diastolic blood pressure; SBP: systolic blood pressure. 
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Table 2.  Hazard ratios of all-cause and cardiovascular mortality according to heart rate in the Kangwha cohort. 
All-cause mortality Cardiovascular mortality 
Univariate*   Multivariate# Univariate* Multivariate# Heart rate, beats/min 
HRs (95% CI) HRs (95% CI) HRs (95% CI) HRs (95% CI) 
Men         
< 61 1.07 (0.91–1.26) 1.08 (0.92–1.27) 1.06 (0.88–1.27) 1.00 (0.83–1.21) 
61–79 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 
≥ 80 1.16 (1.04–1.29) 1.10 (1.00–1.21) 1.35 (1.20–1.51) 1.15 (1.02–1.25) 
Women         
< 61 1.07 (0.92–1.25) 1.09 (0.94–1.27) 0.94 (0.80–1.10) 1.04 (0.88–1.22) 
61–79 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference 
≥ 80 1.24 (1.11–1.38) 1.20 (1.07–1.33) 1.24 (1.11–1.38) 1.11 (1.03–1.28) 
*Adjusted for age; #Adjusted for age, education, smoking, drinking, body mass index, occupation, chronic disease and blood pressure. HRs: hazard ratios. 
Table 3.  Combined effect of heart rate and hypertension by JNC-8 on all-cause and cardiovascular mortality in the Kangwha cohort. 
All-cause mortality Cardiovascular mortality Category of heart rate and 
BP level n HRs (95% CI) n HRs (95% CI) 
Men 
Normal (< 120/80 mm Hg) 
      
< 61 beats/min 29 1.25 (0.67–2.34) 2 2.67 (0.51–13.85)
61–79 beats/min 162 1.00 Reference 18 1.00 Reference 
≥ 80 beats/min 46 1.69 (0.97–2.93) 3 4.32 (1.03–18.28)
Prehypertension (120–139/80–89 mmHg)       
< 61 beats/min 89 1.01 (0.63–1.60) 11 1.36 (0.32–5.75) 
61–79 beats/min 773 1.15 (0.88–1.55) 132 2.03 (0.79–5.02) 
≥ 80 beats/min 290 1.43 (1.00–1.92) 40 3.01 (1.07–8.28) 
Stage 1 hypertension (140–159/90–99 mmHg)       
< 61 beats/min 23 2.40 (0.96–2.07) 4 10.1 (1.97–17.64)
61–79 beats/min 173 1.26 (0.81–1.59) 35 5.59 (1.99–10.07)
≥ 80 beats/min 67 0.67 (0.34–1.31) 12 0.83 (0.09–7.16) 
Stage 2 hypertension (≥ 160/ ≥ 100 mmHg)        
Heart rate < 61 beats/min 33 1.23 (0.77–1.93) 6 6.76 (1.28–35.98)
Heart rate 61–79 beats/min 221 1.22 (0.77–1.93) 49 5.74 (1.94–17.44)
Heart rate ≥ 80 beats/min 91 1.48 (0.85–2.55) 28 8.34 (2.52–28.19)
Women  
Normal (< 120/80 mm Hg) 
      
< 61 beats/min 20 1.34 (0.55–3.24) 2 1.32 (0.15–11.43)
61–79 beats/min 135 1.00 Reference 25 1.00 Reference 
≥ 80 beats/min 55 2.29 (1.18–4.41) 10 3.15 (0.75–13.3) 
Prehypertension (120–139/80–89 mmHg)       
< 61 beats/min 114 1.80 (1.10-2.97) 24 2.72 (0.88–8.32) 
61–79 beats/min 783 1.95 (1.33–2.82) 155 2.38 (0.90-5.80) 
≥ 80 beats/min 199 2.23 (1.31–3.26) 36 3.54 (1.16–9.21) 
Stage 1 hypertension (140–159/90–99 mmHg)       
< 61 beats/min 22 2.96 (1.23–4.74) 3 3.25 (0.61–16.71)
61–79 beats/min 212 2.06 (1.30-3.16) 50 4.11 (1.41–9.93) 
≥ 80 beats/min 75 2.73 (1.76–4.92) 16 4.50 (1.59–16.32)
Stage 2 hypertension (≥ 160/ ≥ 100 mmHg)        
< 61 beats/min 39 3.76 (1.45–9.77) 6 6.13 (0.71–53.85)
61–79 beats/min 302 3.18 (2.03–5.00) 65 7.13 (2.62–19.88)
≥ 80 beats/min 122 3.40 (1.89–6.21) 25 5.95 (1.59–22.97)
Adjusted for age, education, smoking, drinking, body mass index, occupation and chronic disease. BP: blood pressure; HRs: hazard ratios; JNC-8: eighth report 
of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. 
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Women with resting heart rate ≥ 80 beats/min with 
pre-hypertension had significantly higher hazard ratio for 
all-cause and CVD mortality (2.23 and 3.54, respectively) 
than those in the reference group, as well as in stage 1 or 
stage 2 hypertension. The hazard ratios for CVD mortality 
associated with the stage 1 hypertension increased from 
3.25 (95% CI: 0.61–16.71) for resting heart rate < 61 
beats/min to 4.11 (95% CI: 1.41–9.93) for resting heart rate 
61–79 beats/min, and 4.50 (95% CI: 1.59–16.32) for resting 
heart rate ≥ 80 beats/min among women. Women with a 
resting heart rate ≥ 80 beats/min and stage 2 hypertension 
had the highest hazard ratios for CVD mortality, 5.95 (95% 
CI: 1.59–22.97; Table 3). 
The association seemed to be stronger in the JNC-8 hy-
pertension groups. In JNC-7 stage 2 hypertension and the 
resting heart rate faster than 80 group, the highest hazard 
ratios were for cardiovascular mortality 4.23 (95% CI: 
2.21–9.58) in men and 3.52 (95% CI: 2.01–5.88) in women 
(Online data Table S1, Table S2). 
4  Discussion 
We report the findings of survival analysis examining the 
combined effect of resting heart rate and hypertension on 
all-cause and CVD mortality among Korean men and 
women over a 20.8-year follow-up period in the Kangwha 
cohort. ERHR alone and in combination with hypertension 
increased the risks of all-cause and CVD mortality. These 
associations remained evident for both men and women 
after controlling for the confounding effects of other poten-
tial risk factors including age, BMI, education, occupation, 
chronic disease, cigarette smoking, and alcohol consump-
tion. The hazard ratio for mortality due to CVDs was par-
ticularly high in patients with both ERHR and hypertension. 
The association between resting heart rate and high sys-
tolic BP is consistent with previous studies where resting 
heart rate was associated with high BP.[10,2325] In this study, 
resting heart rate ≥ 80 beats/min was associated with a high 
risk of all-cause mortality, compared to a heart rate of 61–79 
beats/min for both genders. This was consistent with previ-
ous studies that showed evidence of the highest risk of 
all-cause mortality for people with ERHR.[22] Further, al-
though the relationship between ERHR and CVD mortality 
varied,[7] it was associated with an increased risk of CVD 
mortality in both men and women. 
It was essential to consider possible mechanisms of the 
interaction between ERHR and hypertension, and mortality. 
Several studies claimed that over-activity of the sympathetic 
nervous system might be responsible for the increase in both 
heart rate[8,26,27] and BP.[27] ERHR measured in the supine 
position reflected a heightened sympathetic tone that in the 
long- term could cause deleterious cardiovascular altera-
tions.[28] ERHR was frequently associated with high BP; 
however, these two factors seemed to have additive effects 
on CVD risk. Several epidemiological studies have shown 
that the risk associated with ERHR persisted even after ad-
justment for BP levels.[29] Moreover, other studies have 
demonstrated that the increase in CVD risk in individuals 
with ERHR could be even higher in hypertensive than nor-
motensive individuals.[11,13,25] 
Hazard ratios for mortality according to resting heart rate 
were 1.10 to 1.24. These were relatively low compared to 
the hazard ratios of the combined groups, which were as 
high as 8.34 and 5.95 for the cardiovascular mortality com-
bined with higher heart rate in men and women, respec-
tively. In women, the hazard ratios of the stage 2 hyperten-
sion group were higher than those of stage 1 hypertension 
group, which had higher hazard ratios than the prehyperten-
sion group. The hazard ratios of stage 2 hypertensive indi-
viduals were even higher, even in low heart rate group (3.76, 
6.13) than those of stage 1 hypertension group with higher 
heart rate (2.73, 4.50), which implies the impact of BP 
might be stronger than that of heart rate. However, in men, 
there was no significant difference from the risk of reference 
groups in stage 1 hypertension groups and stage 2 hyperten-
sion group concerning all-cause mortality. This is difficult 
to explain but we cannot exclude the possibility of the in-
fluence from several unidentified chronic heart failure pa-
tients in those groups. The prognosis of chronic heart failure 
has been known to be superior in higher heart rate groups 
than lower heart rate groups.[15] 
Ivabradine is an If channel inhibitor that lowers ERHR, 
which improves cardiovascular mortality in chronic heart 
failure patients[30] and symptoms associated with inappro-
priate sinus tachycardia.[31] Presently, there was an increased 
risk of cardiovascular mortality in individuals with ERHR 
with hypertension. However, therapeutic value of the heart 
rate lowering treatment for this risk group remains unex-
plored. Our study had notable strengths. The prospective 
study design minimized recall bias. The sample size was 
larger and the follow-up period (20.8 years) was longer than 
other studies.  
Several potential limitations should be noted. We did not 
include the use of cardiovascular and antihypertensive drugs 
possibly affecting resting heart rate and BP into the group of 
confounders. However, at the time of the baseline examina-
tion, the use of these drugs was > 10% in Korea.[32] Sec-
ondly, the level of physical activity of participant was not 
evaluated. But, 80%–87% of participants were farmers, so 
would be expected to have little difference in that regard.[19] 
578 Ryu M, et al. Resting heart rate and hypertension on mortality 
 
Journal of Geriatric Cardiology | jgc@jgc301.com; http://www.jgc301.com 
Because most of the participants (82.8%) were engaged in 
agriculture, we adjusted for occupation as a proxy for phys-
ical activity. 
In conclusion, individuals with coexisting ERHR and 
hypertension are at the greater risk for all-cause (in women) 
and cardiovascular mortality (in both men and women) 
compared to those with either ERHR or hypertension alone. 
These findings also suggest that ERHR should not be re-
garded as a less serious risk factor in elderly hypertensive 
patients than those with normal BP among Koreans. 
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